Medical Specialties Commons^™

Acute Upper Gastrointestinal Bleeding In Post Covid-19 Patients Receiving Direct Oral Anticoagulants As Thromboprophylaxis, Ahmed Fawzy Selim, Mohamed Galal Flefel, Mohamed Sami Torky, Mohamed Abdel-Samiee, Mohamed Elsayed Sarhan

Al-Azhar International Medical Journal

Background: A hypercoagulable state is one of the main pathologic events in COVID-19 patients.

Aim of the study: To assess the possible bleeding sources and proper endoscopic interventions in patients cleared from COVID-19 but still receiving direct oral anticoagulants (DOACs).

Methods: We conducted this prospective study on 305 patients with first-attack upper gastrointestinal bleeding, recently finished COVID-19 treatment, and still using DOACs as a thromboprophylaxis.

Results: DOAC used were Rivaroxaban 10 mg once daily in 150 (49.18%) patients, Apixaban 2.5 mg BID in131 (42.95%) patients, Apixaban 5 mg BID in 15 (4.92%) patients, Rivaroxaban 20 mg in 9 (2.95%) patients. …

Role Of Imaging In Evaluation Of Deep Venous Thrombosis And Pulmonary Embolism In Covid-19 Patients, Ahmed Mohamed Eldeeb, Ali Abd Elhady El-Sayed, Mohamad Fawzy Mahmoud Allam

Al-Azhar International Medical Journal

Background: As of June 30, 2020, COVID-19, the coronavirus illness, continues to pose a hazard to public health worldwide, accounting for over 500,000 deaths and over 10 million cases.

Objective: To characterize the imaging results of COVID-19-positive patients who had acute venous thromboembolic events in the pulmonary or lower limb venous circulation and ascertain the frequency of thromboembolic consequences in COVID-19-positive patients.

Patients and Methods: This prospective study involved 30 patients with proven COVID-19 infection who first developed thromboembolic symptoms at Dar-Elshefaa Specialty Hospital. Six months were dedicated to the research.

Results: In the present investigation, the mean BMI of …

Liver Biochemical Abnormalities Among Covid-19 Patients, Sahar Hassan Abd-Allah, Ashraf Mohammad Elkabeer, Ahmed Mohamed Mostafa, Ayman Abd Elaziz Abd Elrhman, Ebtisam Showky Ahmed Hassanin

Al-Azhar International Medical Journal

Background: The sever acute respiratory syndrome corona virus-2 (SARS_CoV-2) is a novel Corona virus that causes Corona virus disease 2019 (COVID- 19). Except for respiratory symptoms, COVID-19 patient often develop different degrees of liver injury. Notably, COVID-19 patients with pre-existing liver diseases, especially liver cirrhosis, have higher incidence of liver biochemical abnormality, liver injury, and even hepatic decompensation event. Aim: To determine the liver biochemistry changes in COVID-19 patients. Patients and methods: In this retrospective study was conducted in quarantine department, Assuit Chest Hospital was conducted on 761 COVID-19 patients. Patients were divided into 2 groups: hepatic and non-hepatic groups. …

Clinical Patterns Of Covid19 In Different Types Of Ckd Patients, Mohamed Elshahat Mahmoud Mousa, Ahmed Alaa Eldin Ahmed, Alsayed Mohamed Rashed, Mohammad Abo-Ghabsha

Al-Azhar International Medical Journal

Background - Nephrologists have been at the forefront of clinical care of patients with COVID-19 as kidney-related complications, including chronic kidney disease (CKD), glomerular disease, and severe electrolyte derangements, are frequently encountered.

Aim - to estimate the effect of Covid-19 viral infection on chronic kidney disease patients and to determine clinical characteristics of disease.

Patients and Methods - A retrospective case study for 50 patients with Chronic Kidney Disease from stage 1 to stage 5 presented with covid 19 infection which confirmed by PCR to El Sheikh Zyed Al Nahyan hospital from 1st of August 2021 to 1st of January …

Prevalence Of Post Covid Psychiatric Symptoms In Sample Of Recovered Patients, Reda Roshdy Mahmoud Mohammed, Mohamed Elsayed Elmetwalli Elsayed Elbasyouni, Mohammed Mahmoud Abdalrahman Hamouda, Ismail Sayed Mohamed Sadek

Al-Azhar International Medical Journal

Background: Coronavirus disease (COVID-19) is a new strain that was never recognized in humans before. It was discovered in 2019 and its common signs include fever, respiratory symptoms; cough and dyspnea.

Aim of the Work: To investigate whether there are any psychiatric symptoms in patient who got COVID-19 infection or not. Subjects and Methods: This case control involved 132 subjects divided into a case group of 66 patients who were treated in tertiary care at Al-Hussein and Sayed Galal Hospitals, Al-Azhar University and a control group of another 66 patients who didn’t get infection. The Symptom Checklist 90 Revised (SCL-90-R) …